cerrar
Tagged with GEN

Interview: Kurt Stoeckli – Managing Director, Glenmark…
The Chief Scientific Officer and President of Glenmark Pharmaceuticals Swiss R&D Center elaborates on Glenmark’s endeavor to venture up the…

Interview: Claude Fischlewitz – Managing Director,…
The managing director of Stallergenes Greer Switzerland, Claude Fischlewitz, explains how he has gone about revitalizing the company’s presence in…

Interview: Jurgi Camblong – CEO, Sophia Genetics,…
As Artificial Intelligence and Next Generation Sequencing started to converge, Sophia Genetics was created to bring the world towards an era of…

Interview: Lee-Cheng Liu – President & CEO, EirGenix,…
Lee-Cheng (L-C) Liu, President and CEO of EirGenix, one of Taiwan’s fastest growing companies in the biotech field, documents the progress made in…

Interview: Guillaume Corpart – Founder & Managing…
The founder and Managing Director of Global Health Intelligence (GHI), Guillaume Corpart highlights the value of competitive intelligence for medical…

Interview: Mark Griffiths – Group CEO, Dishman Group
“Get it done! That is what CARBOGEN AMCIS is all about!” – The CEO of the Swiss drug development and commercialization services company…

Interview: Thomas Bohn – Executive Director, Greater Geneva…
The Executive Director of the Greater Geneva Bern area, Western Switzerland’s investment promotion agency, elaborates on the unique assets the…

Interview: Stella Koukaki, Theodore Panagopoulos, Panagiotis…
The management team of PharOS discuss the company’s move from generics consultancy to co-developer, surviving in the Greek market, and…

Interview: Petar Vazharov – Executive Vice President APAC,…
Petar Vazharov, Alvogen’s executive vice president for Asia Pacific, and, Jefferson Wang, general manager of Lotus, provide insights into Lotus’…

Interview: Ming-Chu Hsu – Chairman & CEO, TaiGen,…
The Chairman & CEO of TaiGen Biotechnology discusses the growth opportunities that the company holds in China, its main target market, and…

Staying the Course in Greece
Despite the difficulties of the financial crisis and subsequent austerity legislation, pharma firms implanted in Greece have nonetheless continued to…

John Bouros – CEO, Alvion Pharmaceuticals, Greece
John Bouros CEO and founder of Alvion Pharmaceuticals in Greece on the opportunities inherent in any economic crisis, the growth of the Greek generics…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here